Compare Injective (INJ) vs Chainlink (LINK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Injective vs Chainlink — how do they compare? Injective trades at Rp81,797 (market cap Rp8,18T, Rp780,33M 24h volume), while Chainlink trades at Rp158,185 (market cap Rp118,41T, Rp3,93T 24h volume). The key difference: Chainlink is far larger — about 14.5× Injective's market cap, and Chainlink's supply is capped (748,1M / 1B LINK (75%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 37 Days and Chainlink for 62 Days on average.
| INJ | LINK | |
|---|---|---|
Market Cap | Rp8,18T | Rp118,41T |
Volume (24h) | Rp780,33M | Rp3,93T |
Circulating Supply | 100M INJ | 748,1M / 1B LINK (75%) |
Typical Hold Time | 37 Days | 62 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INJ is currently trading at Rp81,847 with a market cap of Rp8.18 trillion, showing bearish technical signals with moving averages indicating selling pressure while oscillators remain neutral. The token faces immediate resistance at Rp82,576 with support at Rp81,456. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding patterns among investors.
Overall outlook remains cautious with technical indicators favoring bearish momentum. Key opportunities include potential bounce from support levels, while major risks involve continued selling pressure and crypto market volatility. Investors should monitor network adoption metrics and exchange liquidity closely.
Chainlink (LINK) is trading at Rp158,289 with a market cap of Rp118.41 trillion, showing bullish technical momentum with strong moving average signals. The token is approaching key resistance at Rp159,591 while maintaining support at Rp155,489. Recent developments include positive regulatory sentiment with former Chainlink executives joining key positions, though oscillators remain neutral suggesting potential consolidation ahead.
Overall outlook remains cautiously optimistic with strong technical momentum but overbought RSI signals. Key opportunities include growing oracle network adoption and regulatory developments, while risks include high volatility and potential profit-taking near resistance levels. Investors should monitor support levels closely.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →About Chainlink
Founded in 2017 by Sergey Nazarov , Chainlink is a blockchain abstraction layer that enables universally connected smart contracts. Through a decentralized oracle network, Chainlink allows blockchains to securely interact with external data feeds, events and payment methods, providing the critical off-chain information needed by complex smart contracts to become the dominant form of digital agreement.
Read more on LINK →
